2025-10-05 - Analysis Report
Okay, here's a report based on the provided data, formatted for clarity and including analysis:

## ALB (Albemarle Corp) Stock Analysis

Albemarle Corp is a global specialty chemicals company with leading positions in lithium, bromine, and catalysts.

### 1. Performance Overview

*   **Ticker:** ALB
*   **Company:** Albemarle Corp
*   **Cumulative Return:** -14.84%
*   **Benchmark (VOO) Cumulative Return:** 98.51%
*   **Deviation:** -113.35%
*   **Relative Deviation:** 2.1 (Indicates ALB is performing near the low end of its historical range relative to VOO.)

**Analysis:** ALB has significantly underperformed the S&P 500 (VOO) over the period. The negative deviation highlights this underperformance.  The relative deviation suggests the underperformance is not unusual based on historical trends.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | 85.0%   | 68.0%   | 56.0%   | 0.1    | 15.1   |
| 2016-2018  | 9.0%    | 68.0%   | -6.0%   | 0.0    | 9.1    |
| 2017-2019  | -44.0%  | 73.9%   | -66.0%  | 0.1    | 8.6    |
| 2018-2020  | 44.0%   | 79.4%   | 20.0%   | 0.2    | 17.4   |
| 2019-2021  | 149.0%  | 79.4%   | 103.0%  | -0.1   | 27.5   |
| 2020-2022  | 148.0%  | 79.9%   | 149.0%  | 0.5    | 25.5   |
| 2021-2023  | -26.0%  | 81.9%   | -27.0%  | 0.5    | 17.0   |
| 2022-2024  | -152.0% | 81.9%   | -172.0% | 0.3    | 10.1   |
| 2023-2025  | -236.0% | 81.9%   | -299.0% | -0.4   | 10.4   |

**Analysis:**

*   **CAGR:**  Fluctuates wildly, showing periods of strong growth and significant decline. Recent years have seen sharp declines.
*   **MDD:** High Maximum Drawdown values indicate significant risk and volatility.
*   **Alpha:**  Often negative, indicating underperformance relative to the benchmark.  Recent years show extremely negative alpha.
*   **Beta:** Generally low, suggesting ALB is less sensitive to market movements (S&P 500).

### 2. Recent Stock Price Movement

*   **Current Price:** 88.22
*   **Previous Close:** 87.61
*   **Change:** 0.7
*   **5-Day Moving Average:** 84.37
*   **20-Day Moving Average:** 81.03
*   **60-Day Moving Average:** 78.53

**Analysis:** The stock price is above its 5, 20, and 60-day moving averages, indicating a short-term upward trend. The positive change from the previous close supports this.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 62.99 (Approaching overbought territory but not yet there.)
*   **PPO:** 0.70 (Positive, suggesting a slight upward trend in price momentum.)
*   **Hybrid Signal:** "cash\_0% Buy 100% of cash (12 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00)"
*   **Delta Previous Relative Divergence (20-day):** 0.1 (Positive, suggesting short-term upward momentum.)
*   **Expected Return (%):** 1627.6 (Very high, suggesting significant potential long-term outperformance relative to the S&P 500 if investing from this point.)

**Analysis:**

*   The MRI suggests the stock is a good investment from a risk perspective.
*   The RSI indicates increasing buying pressure but is not yet at an overbought level.
*   The positive PPO supports the recent price increase.
*   The high expected return suggests a potentially very lucrative long-term investment, though this should be viewed with caution, as it's a forecast.
*   The recent price increase of 0.7 relative to the previous close may reflect volatility or news events.

### 4. Recent News & Significant Events

*   **Positive:**
    *   "2 Dirt Cheap Dividend Stocks to Buy Before It's Too Late" - Could attract value investors.
    *   "Albemarle (ALB): Revisiting Valuation Following Recent Sector Swings" - Indicates ongoing investor analysis.
    *   "Lithium Americas Spikes As U.S. Confirms Stake After MP Materials, Intel Investments" - Positive for the lithium sector, potentially benefitting ALB.
*   **Negative/Neutral:**
    *   "Albemarle (ALB) Stock Drops Despite Market Gains: Important Facts to Note" - Highlights recent underperformance.
    *   "Albemarle Corporation to Release Third Quarter 2025 Earnings Results on Wednesday, November 5, 2025" - Upcoming earnings release, potential catalyst for price movement.

**Analysis:** Recent news is mixed, with some articles highlighting value opportunities and positive developments in the lithium sector, while others point out recent underperformance. The upcoming earnings release could be a key event.

#### 4-2) Analyst Opinions

*   **Consensus:** Hold
*   **Mean Rating:** 2.64 (Hold)
*   **Number of Opinions:** 22
*   **Target Price:**
    *   Average: 87.29
    *   High: 200.00
    *   Low: 58.00

**Analysis:**

*   The consensus rating is "Hold," indicating analysts are generally neutral on the stock.
*   The wide range in target prices (58.00 to 200.00) suggests significant uncertainty about the stock's future performance.  The average target price is slightly below the current price.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-08-04 | -0.16 | 1.33 B$    |
| 2025-04-30 | 0     | 1.08 B$    |
| 2024-11-06 | -9.45 | 1.35 B$    |
| 2024-07-31 | -1.96 | 1.43 B$    |
| 2025-08-04 | -1.96 | 1.43 B$    |

**Analysis:**

*   The company has reported mixed EPS results, with recent quarters showing losses.
*   Revenue has fluctuated but generally remained above $1 billion.
*   The significant loss in 2024-11-06 raises concerns.

### 6. Financial Information

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $1.33B  | 14.80%        |
| 2025-03-31 | $1.08B  | 14.51%        |
| 2024-12-31 | $1.23B  | 11.22%        |
| 2024-09-30 | $1.35B  | -7.68%        |
| 2024-06-30 | $1.43B  | -0.74%        |

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-06-30 | $10.24B   | 0.22%     |
| 2025-03-31 | $10.03B   | 0.41%     |
| 2024-12-31 | $9.96B    | 0.76%     |
| 2024-09-30 | $10.24B   | -10.44%   |
| 2024-06-30 | $11.22B   | -1.68%    |

**Analysis:**

*   Recent quarters show decent revenue, but profit margins have been volatile, with some quarters showing losses.
*   ROE has also been inconsistent, with negative values in some quarters.
*   Equity has fluctuated, indicating changes in the company's financial structure.

### 7. Overall Summary

Albemarle (ALB) has underperformed the S&P 500 significantly, but recent technical indicators show a potential for short-term upward momentum. Analyst opinions are neutral, with a wide range of target prices reflecting uncertainty. Recent earnings have been mixed, with some losses reported. The MRI suggests the stock is a good investment from a risk perspective, and the expected return is very high, but these should be tempered with caution. Recent news is mixed, with both positive and negative headlines. Upcoming earnings release in November could be a key event.

**Recommendation:**  Given the mixed signals, a cautious approach is warranted. Monitor the upcoming earnings release and assess the company's progress in improving profitability and revenue growth. The positive technical indicators and high expected return suggest potential, but the recent underperformance and analyst uncertainty require careful consideration. Long-term investors might find value, but due diligence is crucial.
